drugset / Trial / NCT04830358
Safety and Immunogenicity of the 'EuPCV15' in Healthy Korean Adults
RandomizedParallel-groupSingle-blindPrevention
Summary
The safety and immunogenicity of EuPCV15 compared to Prevenar13 are assessed in healthy adults.
Timeline
- Start
- 2020-05-28
- Primary completion
- 2020-08-14
- Completion
- 2021-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EuPCV15 | Vaccine | — | Intramuscular |
| Comparator | Prevnar 13 | Vaccine | — | Intramuscular |